Kiryat Bialik, Israel

Mordechay Rozenzon

This inventor holds 1 USPTO granted patent. Top assignee: Equashield Medical Ltd.. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mordechay Rozenzon

Introduction

Mordechay Rozenzon is an accomplished inventor based in Kiryat Bialik, Israel. He has made significant contributions to the field of pharmaceutical preparation technologies. His innovative work focuses on improving the efficiency and accuracy of pharmaceutical devices.

Latest Patents

Mordechay Rozenzon holds a patent for "Pharmaceutical preparation methods and systems using imaging technologies." This patent describes systems and methods for determining the presence of fluid or air in a non-opaque tube within a pharmaceutical preparation device. The system includes processing circuitry that receives a camera image of the non-opaque tube, which is positioned in front of a patterned background. The image processing techniques allow for the identification of regions within the tube, enabling the determination of content characteristics.

Career Highlights

Mordechay Rozenzon has dedicated his career to advancing pharmaceutical technologies. His work has led to the development of innovative systems that enhance the preparation of medications. He is currently associated with Equashield Medical Ltd., where he continues to contribute to the field.

Collaborations

Mordechay has collaborated with notable professionals in his field, including Eric Shem-Tov and Boaz Slav. These collaborations have further enriched his work and expanded the impact of his innovations.

Conclusion

Mordechay Rozenzon's contributions to pharmaceutical preparation technologies exemplify the importance of innovation in healthcare. His patented methods and systems are paving the way for more efficient pharmaceutical practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…